Breaking News Instant updates and real-time market news.

EIGR

Eiger BioPharmaceuticals

$10.50

0.005 (0.05%)

11:31
12/19/18
12/19
11:31
12/19/18
11:31

Eiger BioPharmaceuticals price target raised to $47 from $44 at BTIG

BTIG analyst Robert Hazlett raised his price target for Eiger BioPharmaceuticals to $47 from $44 after the company announced that FDA granted Lonafarnib Breakthrough Therapy for the treatment of Progeria and progeroid laminopathies. The analyst argues that Breakthrough status adds material regulatory and clinical validation to Lonafarnib's accelerated efforts in Progeria and should enable more rapid FDA review. An NDA filing istargeted for early 2019, he notes. Hazlett now models U.S. approval in Progeria in 2019, a Priority Review Voucher awarded and monetized around yearend 2019, and use in progeriod laminopathies, which modestly lifts NPV estimates. The analyst reiterates a Buy rating on the shares.

EIGR Eiger BioPharmaceuticals
$10.50

0.005 (0.05%)

08/27/18
JEFF
08/27/18
NO CHANGE
Target $25
JEFF
Buy
Jefferies sees good entry point for Eiger BioPharmaceuticals ahead of update
Jefferies analyst Maury Raycroft believes current Eiger BioPharmaceuticals share levels offer a good entry point ahead of news from the Phase III D-LIVR endpoints in hepatitis delta virus based on FDA feedback. The analyst does not anticipate major surprises around the update and expect the outcome to be viewed positively. The announcement should give the stock a bump and add momentum to a second half of 2018 run-up that will include several key catalysts, Raycroft tells investors in a research note. He sees little downside risk in Eiger shares and keeps a Buy rating on the name with a $25 price target.
09/04/18
PIPR
09/04/18
NO CHANGE
Target $24
PIPR
Overweight
Eiger can file lonafarnib without additional studies, says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff says feedback from the FDA will enable Eiger BioPharmaceuticals to file an investigational new drug application for lonafarnib to treat orphan indication Hutchinson-Gilford Progeria syndrome as soon as 2019. Importantly, this accelerates anticipated timelines because Eiger is not required to conduct additional clinical studies for approval, Tenthoff tells investors in a research note. He beieves that if approved, Eiger "could gain a valuable Pediatric Priority Review Voucher shared with the Progeria Research Foundation." The analyst reiterates an Overweight rating on the shares with a $24 price target.
10/17/18
PIPR
10/17/18
NO CHANGE
Target $24
PIPR
Overweight
Piper reiterates Overweight on Eiger after positive hypoglycemia data
Eiger BioPharmaceuticals last night reported positive top-line Phase II Prevent data on avexitide to treat post-bariatric hypoglycemia, Piper Jaffray analyst Edward Tenthoff tells investors in a research note. The analyst points out that both primary and secondary endpoints achieved statistical significance showing clinically meaningful increases in glucose nadir and decreased insulin spike following induction of a hypoglycemic attack. He reiterates an Overweight rating on Eiger shares with a $24 price target. Tenthoff remains focused on Eiger's hepatitis delta virus franchise with full 48-week Phase II interferon lambda data at the annual American Association for the study of Liver Diseases meeting in November and the Phase III D-LIVR trial start of lonafarnib in Q4.
10/18/18
PIPR
10/18/18
NO CHANGE
Target $24
PIPR
Overweight
Eiger positive data opens HDV triple combo opportunity, says Piper Jaffray
Eiger BioPharmaceuticals last night announced positive end-of-treatment data from the Phase II study of InterferonLambda in hepatitis delta virus patients, Piper Jaffray analyst Edward Tenthoff tells investors in a research note. Importantly, Interferon-Lambda continued to show improved tolerability versus IFN-alfa, which should enable long-term dosing, the analyst contends. He believes the positive data opens up the opportunity for a hepatitis delta virus triple combo. Tenthoff reiterates an Overweight rating on shares of Eiger with a $24 price target.

TODAY'S FREE FLY STORIES

SPHHF

Sophos Group

$0.00

(0.00%)

19:18
10/14/19
10/14
19:18
10/14/19
19:18
Downgrade
Sophos Group rating change  »

Sophos Group downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RETA

Reata Pharmaceuticals

$100.37

4.57 (4.77%)

, GLUU

Glu Mobile

$5.50

0.025 (0.46%)

18:44
10/14/19
10/14
18:44
10/14/19
18:44
Hot Stocks
Fly Intel: After Hours Movers »

HIGHER: Reata Pharma…

RETA

Reata Pharmaceuticals

$100.37

4.57 (4.77%)

GLUU

Glu Mobile

$5.50

0.025 (0.46%)

SENS

Senseonics

$0.83

-0.025 (-2.92%)

AKRX

Akorn

$3.81

-0.105 (-2.69%)

SFIX

Stitch Fix

$21.21

-0.62 (-2.84%)

ASB

Associated Banc-Corp

$19.92

0.12 (0.61%)

EHTH

eHealth

$53.12

-2.86 (-5.11%)

BLMN

Bloomin' Brands

$18.15

-0.83 (-4.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 24

    Oct

  • 31

    Oct

  • 06

    Nov

  • 13

    Nov

CPA

Copa Holdings

$99.31

-0.045 (-0.05%)

17:58
10/14/19
10/14
17:58
10/14/19
17:58
Hot Stocks
Copa Holdings reports September capacity down 5.5%, traffic down 0.7% »

Copa Holdings released…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

SPY

SPDR S&P 500 ETF Trust

$296.06

-0.2 (-0.07%)

, SPX

S&P 500

$0.00

(0.00%)

17:35
10/14/19
10/14
17:35
10/14/19
17:35
Periodicals
Path to Brexit deal seen with potential Irish border solution, Telegraph says »

After a positive day of…

SPY

SPDR S&P 500 ETF Trust

$296.06

-0.2 (-0.07%)

SPX

S&P 500

$0.00

(0.00%)

EWU

iShares MSCI United Kingdom ETF

$31.37

-0.27 (-0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEDG

SolarEdge

$89.14

0.19 (0.21%)

, ISCA

International Speedway

$45.21

0.165 (0.37%)

17:22
10/14/19
10/14
17:22
10/14/19
17:22
Hot Stocks
S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices »

SolarEdge Technologies…

SEDG

SolarEdge

$89.14

0.19 (0.21%)

ISCA

International Speedway

$45.21

0.165 (0.37%)

GLUU

Glu Mobile

$5.50

0.025 (0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 06

    Nov

  • 13

    Nov

  • 03

    Dec

GLUU

Glu Mobile

$5.50

0.025 (0.46%)

, SEDG

SolarEdge

$89.14

0.19 (0.21%)

17:18
10/14/19
10/14
17:18
10/14/19
17:18
Hot Stocks
Breaking Hot Stocks news story on Glu Mobile, SolarEdge »

Glu Mobile to replace…

GLUU

Glu Mobile

$5.50

0.025 (0.46%)

SEDG

SolarEdge

$89.14

0.19 (0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 13

    Nov

  • 03

    Dec

SEDG

SolarEdge

$89.14

0.19 (0.21%)

, ISCA

International Speedway

$45.21

0.165 (0.37%)

17:17
10/14/19
10/14
17:17
10/14/19
17:17
Hot Stocks
SolarEdge to replace International Speedway in S&P 400 at open on 10/18 »

Nascar Holdings is…

SEDG

SolarEdge

$89.14

0.19 (0.21%)

ISCA

International Speedway

$45.21

0.165 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 03

    Dec

SFIX

Stitch Fix

$21.21

-0.62 (-2.84%)

17:12
10/14/19
10/14
17:12
10/14/19
17:12
Initiation
Stitch Fix initiated at Baird »

Stitch Fix initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

BLMN

Bloomin' Brands

$18.15

-0.83 (-4.37%)

17:12
10/14/19
10/14
17:12
10/14/19
17:12
Downgrade
Bloomin' Brands rating change at Deutsche Bank »

Bloomin' Brands…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QIWI

Qiwi

$20.34

0.09 (0.44%)

17:02
10/14/19
10/14
17:02
10/14/19
17:02
Hot Stocks
Qiwi CFO Vladislav Poshmorga resigned effective October 8th »

QIWI plc announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RLMD

Relmada Therapeutics

$11.10

0.4 (3.74%)

16:51
10/14/19
10/14
16:51
10/14/19
16:51
Hot Stocks
Relmada Therapeutics to announces Phase 2 study results of REL-107 on October 15 »

Relmada Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGFS

AgroFresh Solutions

$2.39

0.125 (5.53%)

16:47
10/14/19
10/14
16:47
10/14/19
16:47
Hot Stocks
AgroFresh awarded $31M in damages in Decco Poast-Harvest lawsuit »

AgroFresh was awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EHTH

eHealth

$53.12

-2.86 (-5.11%)

16:47
10/14/19
10/14
16:47
10/14/19
16:47
Initiation
eHealth initiated at Raymond James »

eHealth initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

GPN

Global Payments

$164.14

1.2 (0.74%)

16:38
10/14/19
10/14
16:38
10/14/19
16:38
Initiation
Global Payments initiated  »

Global Payments initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 31

    Oct

  • 13

    Nov

APTS

Preferred Apartment

$14.41

0.075 (0.52%)

16:36
10/14/19
10/14
16:36
10/14/19
16:36
Hot Stocks
Preferred Apartment names Joel Murphy as CEO, effective January 1, 2020 »

Preferred Apartment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OHI

Omega Healthcare

$43.05

0.65 (1.53%)

16:36
10/14/19
10/14
16:36
10/14/19
16:36
Hot Stocks
Omega Healthcare raises quarterly dividend to 67c from 66c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

RPAY

Repay Holdings

$13.21

-0.07 (-0.53%)

16:35
10/14/19
10/14
16:35
10/14/19
16:35
Hot Stocks
Breaking Hot Stocks news story on Repay Holdings »

Repay Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 19

    Nov

SQ

Square

$61.83

0.29 (0.47%)

16:34
10/14/19
10/14
16:34
10/14/19
16:34
Initiation
Square initiated  »

Square initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 29

    Oct

  • 06

    Nov

FISV

Fiserv

$106.05

0.41 (0.39%)

, FDC

First Data

$0.00

(0.00%)

16:34
10/14/19
10/14
16:34
10/14/19
16:34
Initiation
Fiserv, First Data initiated at UBS »

Fiserv initiated with a…

FISV

Fiserv

$106.05

0.41 (0.39%)

FDC

First Data

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

  • 27

    Oct

LDOS

Leidos

$82.50

-0.66 (-0.79%)

16:31
10/14/19
10/14
16:31
10/14/19
16:31
Hot Stocks
Leidos awarded $926M TSA screening equipment contract »

Leidos was awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 12

    Nov

RETA

Reata Pharmaceuticals

$100.37

4.57 (4.77%)

16:30
10/14/19
10/14
16:30
10/14/19
16:30
Hot Stocks
Breaking Hot Stocks news story on Reata Pharmaceuticals »

Reata Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
10/14/19
10/14
16:30
10/14/19
16:30
Options
Preliminary option volume of 13.7M today »

Preliminary option volume…

FIS

FIS

$132.70

0.69 (0.52%)

16:29
10/14/19
10/14
16:29
10/14/19
16:29
Initiation
FIS initiated at UBS »

FIS initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 19

    Nov

AKRX

Akorn

$3.81

-0.105 (-2.69%)

16:28
10/14/19
10/14
16:28
10/14/19
16:28
Hot Stocks
Akorn gets FDA approval for Betamethasone Dipropionate Lotion, augmented »

Akorn announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

EHTH

eHealth

$53.12

-2.86 (-5.11%)

16:27
10/14/19
10/14
16:27
10/14/19
16:27
Initiation
eHealth initiated at Raymond James »

eHealth initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.